Identification of Pregnancy Adverse Drug Reactions in Pharmacovigilance Reporting Systems: A Novel Algorithm Developed in EudraVigilance
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Identification of Pregnancy Adverse Drug Reactions in Pharmacovigilance Reporting Systems: A Novel Algorithm Developed in EudraVigilance ; day:19 ; month:6 ; year:2024 ; pages:1-10
Drug safety ; (19.6.2024), 1-10
- Creator
-
Zaccaria, Cosimo
Piccolo, Loris
Gordillo-Marañón, María
Touraille, Gilles
Vries, Corinne de
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40264-024-01448-y
- URN
-
urn:nbn:de:101:1-2409102105409.806781315152
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zaccaria, Cosimo
- Piccolo, Loris
- Gordillo-Marañón, María
- Touraille, Gilles
- Vries, Corinne de
- SpringerLink (Online service)
Other Objects (12)
A real-world pharmacovigilance study of FDA adverse event reporting system events for Capmatinib
Pharmacovigilance Study of Infigratinib: A Safety Analysis of the FDA Adverse Event Reporting System
A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib
A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for osimertinib
Pharmacovigilance study of famciclovir in the Food and Drug administration adverse event reporting system database
Delirium Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
A real-world pharmacovigilance study of amivantamab-related cardiovascular adverse events based on the FDA adverse event reporting system (FAERS) database
Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database
Safety assessment of Tafamidis: a real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events
A real-world pharmacovigilance study of FDA adverse event reporting system events for Lutetium-177-PSMA-617
Norwegian farmers' vigilance in reporting sheep showing scrapie-associated signs
The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement
A real-world pharmacovigilance study of FDA adverse event reporting system events for Capmatinib
Pharmacovigilance Study of Infigratinib: A Safety Analysis of the FDA Adverse Event Reporting System
A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib
A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for osimertinib
Pharmacovigilance study of famciclovir in the Food and Drug administration adverse event reporting system database
Delirium Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
A real-world pharmacovigilance study of amivantamab-related cardiovascular adverse events based on the FDA adverse event reporting system (FAERS) database
Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database
Safety assessment of Tafamidis: a real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events
A real-world pharmacovigilance study of FDA adverse event reporting system events for Lutetium-177-PSMA-617
Norwegian farmers' vigilance in reporting sheep showing scrapie-associated signs
The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement
A real-world pharmacovigilance study of FDA adverse event reporting system events for Capmatinib
Pharmacovigilance Study of Infigratinib: A Safety Analysis of the FDA Adverse Event Reporting System
A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib
A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for osimertinib
Pharmacovigilance study of famciclovir in the Food and Drug administration adverse event reporting system database
Delirium Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
A real-world pharmacovigilance study of amivantamab-related cardiovascular adverse events based on the FDA adverse event reporting system (FAERS) database
Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database
Safety assessment of Tafamidis: a real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events
A real-world pharmacovigilance study of FDA adverse event reporting system events for Lutetium-177-PSMA-617
Norwegian farmers' vigilance in reporting sheep showing scrapie-associated signs